Development of resistance byEnterobacter cloacae during therapy of pulmonary infections in intensive care patients
- 1 December 1994
- journal article
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 72 (12) , 1015-1019
- https://doi.org/10.1007/bf00577747
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Relationship between ceftriaxone use and resistance of Enterobacter speciesJournal of Clinical Pharmacy & Therapeutics, 1992
- Clinical significance of beta-lactamase induction and stable derepression in gram-negative rodsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- Development of resistance during antibiotic therapyEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- Type I -Lactamases of Gram-Negative Bacteria: Interactions with -Lactam AntibioticsThe Journal of Infectious Diseases, 1986
- Microbial Resistance to Newer Generation f3-lactam Antibiotics: Clinical and Laboratory ImplicationsThe Journal of Infectious Diseases, 1985
- Inducible β-lactamases and non-hydrolytic resistance mechanismsJournal of Antimicrobial Chemotherapy, 1984
- Emergence of Resistance During Therapy with the Newer -Lactam Antibiotics: Role of Inducible -Lactamases and Implications for the FutureClinical Infectious Diseases, 1983
- Broad-spectrum β-lactam resistance in Enterobacter: emergence during treatment and mechanisms of resistanceJournal of Antimicrobial Chemotherapy, 1983
- In Vivo Selection of Resistance to Multiple Cephalosporins by Enterobacter cloacaeThe Journal of Infectious Diseases, 1983
- Moxalactam therapy of infections caused by cephalothin-resistant bacteria: influence of serum inhibitory activity on clinical response and acquisition of antibiotic resistance during therapyAntimicrobial Agents and Chemotherapy, 1981